端粒酶催化亚单位在恶性肿瘤中的研究进展
Advance on Catalytic Subunit of Telomerase in Tumor
摘要
介绍了端粒酶催化亚单位(hTRT)的结构、功能,以及hTRT在恶性肿瘤的诊断和治疗中的临床意义.
The structure and function of catalytic subunit of telomerase were introduced. The clinical significances of catalytic subunit of telomerase in tumor were summarized.
出处
《北华大学学报（自然科学版）》
CAS
2003年第1期40-42,共3页
Journal of Beihua University（Natural Science）
基金
吉林省教育厅科研基金资助项目 (吉教合字 995 6 )
参考文献13
-
1[1]Blackburn E H. Structure and Function of Telomeres[J].Nature, 1991,350: 569～573.
-
2[2]Allsopp R C, Vaziri H, Patterson C, et al. Telomere Length Predicts Replicative of Human Fibroblasts[J]. Proc Nad Acad Sci USA, 1992,89:10114～10118.
-
3[3]Harley C B. Telomere Loss: Mototic Clock or Genetic Time Bomb[J]. Mutat Res,1991,256(3):271～282.
-
4[4]Rogan E M. Alternations in p53 and p16INKS4 Expression and Telomere Length during Spontaneous Immortalization of Li-Fraumeni Syndrome Fibroblasts[J]. Mol and Cell Biol, 1995,15: 4745～4753.
-
5[5]Meyerson M, Counter C M, Eaton E N, et al. hESZ,The Purative Human Telomerase Catalytic Subunit Gene. Is Upregulated in Tumor Cells and during Immortalization[J]. Ce11,1997,90(4):785～795.
-
6[6]Nakamura T M, Morin G B, Chapman K B, et al.Telomerase Catalytic Subsunit Homologs from Fission Yeast and Human[J]. Science, 1997,277:955～959.
-
7[7]Takakura M, Kyo S, Kanaya T, et al. Cloning of Human Telomerase Catalytic Subunit (hTRT) Gene Promoter and Identification of Proximal Core Promoter Sequences Essential for Transcriptional Activation in Immortalized and Cancer Cells[J]. J Cancer Res, 1999,59(3):551～557.
-
8[8]Horikawa I, Cable P L, Afshari C, et al. Cloning and Characterization of the Promoter Region of Human Telomerase Reverse Transcriptase Gene[J]. J Cancer Res, 1999,59(4):826～830.
-
9[9]Linger J, Hugnes T R, Sherchenk M, et al. Reverse Transcriptase Motifs in the Catalytic Subunit of Telomerase [J]. Science, 1997,276:561～563.
-
10[10]Kim N W, Piatyszek M A, Prowse K R, et al. Specific Association of Human Telomerase Activity with Immortal Cell and Cancer[J]. Science, 1994,266:2011～2015.
-
1张汉英,黎丹戎.端粒、端粒长度、端粒酶活性与卵巢癌发生的关系[J].中国医学文摘（肿瘤学）,2005,19(4):333-334. 被引量：1
-
2张寅.端粒长度与肿瘤[J].中国肿瘤,1999,8(11):512-514. 被引量：1
-
3张志宏,张洪福,叶茂昌,祝怀平,戴海明,李志来,陈传俊,张震东.口腔鳞状细胞癌中端粒酶活性的表达[J].安徽医科大学学报,2000,35(5):346-348. 被引量：1
-
4郭月凤.端粒变异在癌症发生中的作用[J].山西医药杂志,2007,36(1):47-49.
-
5李红梅,辛晓燕.端粒、端粒酶与妇科肿瘤[J].肿瘤防治研究,2000,27(6):492-494.
-
6叶健,任振义.Ku蛋白在肿瘤放射治疗中价值的研究进展[J].全科医学临床与教育,2010,8(4):405-407.
-
7张志宏,叶茂昌,李志来,祝怀平,戴海明,吴冰,朱祖武.端粒酶活性在口腔鳞状细胞癌中的表达研究[J].口腔医学,2002,22(4):179-181. 被引量：1
-
8柏艳红,王显艳,张春.端粒酶和肿瘤发生及其在病理学中的应用[J].齐齐哈尔医学院学报,2003,24(10):1135-1136.
-
9龚维坤.端粒酶与细胞增殖及炎性疾病的关系[J].国外医学（免疫学分册）,2004,27(3):174-177.
-
10王晓莉,金树,李文辉.DNA依赖蛋白激酶与细胞放射敏感性[J].中华放射肿瘤学杂志,2007,16(6):495-496. 被引量：2
